Wednesday, October 19, 2022 by: Lance D Johnson
Tags: badhealth, badmedicine, CDC, coercion, conspiracy, corruption, Dangerous Medicine, deception, Dr. Paul Offit, efficacy, experimentation, FDA, fraud, incompetence, Moderna, omicron, Pfizer, political pressure, scientific fraud, subvariants, vaccine hesitancy, vaccine industry, vaccine wars
This article may contain statements that reflect the opinion of the author
One of the staunchest vaccine proponents of modern times has suddenly become anti-vax, and now has a severe case of vaccine hesitancy. Dr. Paul Offit, director of the Vaccine Education Center at the Children’s Hospital of Philadelphia is now advising against the latest covid-19 vaccines. Dr. Offit, who is a member of the Centers for Disease Control (CDC) Advisory Committee on Immunization Practices, voted against the upcoming covid-19 booster shots. He says the new boosters lack critical data and have been politicized by the Brandon administration, with no regard to their risk of blood clotting, myocarditis and thrombosis with thrombocytopenia syndrome.
Dr. Paul Offit opens his eyes to corruption and fraud of the vaccine industry
Offit’s eyes were finally opened to the corruption and fraud of the vaccine industry at his latest meeting with the Vaccines and Related Biological Products Advisory Committee (VRBPAC). He called the meeting “unusual” and said it “felt like the fix was in” right before the FDA panel voted to reformulate the covid-19 booster shots. Offit said the committee usually weighs the benefits versus the risks but “I didn’t see the benefits.”
He said that “both Moderna and Pfizer presented data during the June 28 meeting and it was not compelling.” Offit continued:
I’ve seen nothing like this. I guess the thing that’s most upsetting to me is normally when you get something from the FDA when we have these meetings, you usually get it a few days before you meet. You usually get a couple of hundred pages.
Here on the other hand, normally you get the EUA [Emergency Use Authorization] submission from the company, which is 85 to 100 pages long, and then you get the FDA’s review of all those data. It’s a very thorough review. Not here though. Here, it was 22 pages from the FDA, which included a half-page on Pfizer’s data and a half-page on Moderna’s data.
Dr. Offit disgusted by political pressure to push covid-19 boosters that have scant evidence of efficacy
Offit said that despite there being no statistical benefits for the vaccine, a shocking 19 out of 21 members voted to approve the new formulation. He added that the Brandon administration desired the approval of the new vaccine and already decided to purchase 105-300 million doses from Pfizer just one day after the vaccine was pushed forward by the FDA committee. He also said the committee’s June 28th meeting was oddly and unusually influenced by biased opinions from the World Health Organization. The approval went through even though 782,900 Americans sought medical attention and hospitalization following the first round of COVID-19 vaccination.
When the Brandon administration announced their gigantic taxpayer-funded purchase, their press release mentioned VRBPAC had just made its decision the day before. “So, you just kind of felt like the fix was in a little bit,” Offit said. “Maybe that’s not the right phrase but it was something they wanted and I felt like we were being led here and with a critical lack of information.”
Offit also criticized the original covid-19 vaccines that were released in mid-December 2020. He said the manufacturers showed a two-fold increase in neutralizing antibodies “but it did not translate into a clinically significant difference in terms of protection against severe disease.” To make matters worse, the vaccines never stopped infection or transmission and only caused side effects and more illness. Offit said the latest reformulations show an even smaller increase in the augmentation of neutralizing antibodies, making their proposed efficacy absolutely meaningless in real world terms.
Offit said the “1.75-fold increase in neutralizing antibodies against omicron” is not a “clinically significant difference” and does not correlated to efficacy. He also said the manufacturers could not prove that the vaccine would protect against BA.4 and BA.5 sub-variants once omicron fully passes through the population.